rs868118584
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_152564.5(VPS13B):c.10939G>A(p.Ala3647Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000136 in 1,613,930 control chromosomes in the GnomAD database, with no homozygous occurrence. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_152564.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS13B | ENST00000358544.7 | c.11014G>A | p.Ala3672Thr | missense_variant | Exon 57 of 62 | 1 | NM_017890.5 | ENSP00000351346.2 | ||
VPS13B | ENST00000357162.7 | c.10939G>A | p.Ala3647Thr | missense_variant | Exon 57 of 62 | 1 | NM_152564.5 | ENSP00000349685.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251462Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135906
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461834Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727224
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74274
ClinVar
Submissions by phenotype
Cohen syndrome Uncertain:2
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 3672 of the VPS13B protein (p.Ala3672Thr). This variant is present in population databases (no rsID available, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 576857). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt VPS13B protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not specified Uncertain:1
DNA sequence analysis of the VPS13 gene demonstrated a sequence change, c.11014G>A, in exon 57 that results in an amino acid change, p.Ala3672Thr. This sequence change has been described in the gnomAD database with a frequency of 0.004% in the African/African-American subpopulation (dbSNP rs868118584). The p.Ala3672Thr change affects a moderately conserved amino acid residue located in a domain of the VPS13B protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Ala3672Thr substitution. This sequence change does not appear to have been previously described in individuals with VPS13B-related disorders. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Ala3672Thr change remains unknown at this time. -
Inborn genetic diseases Uncertain:1
The c.11014G>A (p.A3672T) alteration is located in exon 57 (coding exon 56) of the VPS13B gene. This alteration results from a G to A substitution at nucleotide position 11014, causing the alanine (A) at amino acid position 3672 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
VPS13B-related disorder Uncertain:1
The VPS13B c.10939G>A variant is predicted to result in the amino acid substitution p.Ala3647Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0040% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-100871603-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at